Sensex, Nifty tank almost 1% on promoting in pharma, IT shares after new Trump tariffs on medicine

Benchmark inventory indices Sensex and Nifty tumbled almost 1% on Friday (September 26, 2025), marking their sixth consecutive day of decline, following heavy promoting in pharma and IT shares as U.S. President Donald Trump introduced 100% duties on pharmaceutical medicine from subsequent month.

The 30-share BSE Sensex tanked 733.22 factors or 0.90% to settle at a three-week low of 80,426.46. During the day, it dropped 827.27 factors or 1% to 80,332.41.

The 50-share NSE Nifty tumbled 236.15 factors or 0.95% to an over three-week low of 24,654.70. The index has been on a decline since September 19, tanking over 3 % in six straight periods. Sensex has tumbled by 2,587.50 factors or 3.16% in six periods to Friday.

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14% after Trump’s transfer to impose 100% import tariffs on pharmaceutical medicine from October 1. Wockhardt shares tanked 9.4%.

In his publish on social media platform Truth Social, Trump wrote, “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America.” The US President additional clarified, “IS BUILDING” will likely be outlined as, “breaking ground” and/or “under construction.” There will, subsequently, be no Tariff on these Pharmaceutical Products if development has began.

Among Sensex corporations, Mahindra & Mahindra, Eternal, Tata Steel, Bajaj Finance, Asian Paints, Sun Pharma, Tech Mahindra, Infosys, Tata Consultancy Services and HCL Tech had been the most important laggards.

However, Larsen & Toubro, Tata Motors, ITC and Reliance Industries had been the gainers.

“Indian equities ended sharply decrease on Friday in a broad-based sell-off after the US introduced a steep 100% tariff on imports of branded and patented pharmaceutical merchandise efficient October 1. The sudden transfer rattled already fragile investor sentiment, which was nonetheless digesting the latest hike in H-1B visa charges that triggered heavy promoting in IT counters this week.

“Both IT and healthcare stocks bore the brunt of the sell-off, dragging the broader indices lower as investors rushed to reassess earnings outlooks and export growth prospects,” Ponmudi R, CEO of Enrich Money, a web-based buying and selling and wealth tech agency, stated.

In Asian markets, South Korea’s Kospi, Japan’s Nikkei 225 index, Shanghai’s SSE Composite index and Hong Kong’s Hang Seng ended considerably decrease.

Equity markets in Europe had been buying and selling in constructive territory. US markets ended decrease on Thursday.

Foreign Institutional Investors (FIIs) offloaded equities price ₹4,995.42 crore on Thursday, in accordance with alternate information.

Global oil benchmark Brent crude dipped 0.27% to $69.23 a barrel.

On Thursday, the Sensex tanked 555.95 factors or 0.68% to settle at 81,159.68. The Nifty tumbled 166.05 factors or 0.66% to 24,890.85.